FDA inspection
Qilu Pharmaceutical Co., Ltd.: FDA inspection ending Feb 22, 2019
FDA inspection 1088395 · Voluntary Action Indicated (VAI) · Jinan
Key facts
| Inspection ID | 1088395 |
|---|---|
| Firm | Qilu Pharmaceutical Co., Ltd. |
| FEI number | 3003674637 |
| Address | NO. 243 Gongyebeilu, Licheng |
| City | Jinan |
| Country | China |
| Fiscal year | 2019 |
| Inspection end date | Feb 22, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data